Pitoia, F., Marlowe, R. J., Abelleira, E., Faure, E. N., Bueno, F., Schwarzstein, D., . . . Niepomniszcze, H. (2012). Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer. Hindawi Publishing Corporation.
Citación estilo ChicagoPitoia, Fabián, Robert J. Marlowe, Erika Abelleira, Eduardo N. Faure, Fernanda Bueno, Diego Schwarzstein, Rubén Julio Lutfi, and Hugo Niepomniszcze. Radioiodine Thyroid Remnant Ablation After Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients With High-Risk Differentiated Thyroid Cancer. Hindawi Publishing Corporation, 2012.
Cita MLAPitoia, Fabián, et al. Radioiodine Thyroid Remnant Ablation After Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients With High-Risk Differentiated Thyroid Cancer. Hindawi Publishing Corporation, 2012.